What Are the Benefits of Injectable Ribavirin?

Update Date: Source: Network

There are many types of medications. Whether doctors prescribe medications to us or we take medications ourselves, we need to have a comprehensive understanding of the efficacy of the medications to ensure correct medication use, which can promote the improvement of diseases. Ribavirin for injection is a prescription drug that requires a doctor's prescription for purchase and use. Patients can have a general understanding of the efficacy of this medication. So, what is the efficacy of ribavirin for injection? Let's take a look below.

1. What is the efficacy of ribavirin for injection?

Ribavirin injection is an injectable formulation with ribavirin as its main component. It is a broad-spectrum antiviral drug. Clinically, it is mainly used for acute upper respiratory infections, viral bronchitis, pneumonia, and other conditions caused by respiratory syncytial virus, adenovirus, parainfluenza virus, rhinovirus, and other viruses. The toxicity of this drug is very low, and some patients may experience adverse reactions such as fatigue, fever, chills, dry mouth, and muscle soreness after using the medication. Long-term use may lead to liver function damage, increased bilirubin levels, and symptoms such as nausea, vomiting, and hypotension. It should be administered intravenously by slow drip infusion for more than 20 minutes each time, with a course of 3 to 7 days. It should be diluted with sodium chloride injection or 5% glucose injection to a concentration of 1mg per 1ml for intravenous slow drip infusion. For adults, the dosage is 0.25 to 0.5g twice daily. For children, the dosage is 5 to 7.5mg/kg per weight, twice daily.

2. Precautions for ribavirin injection

1. Caution should be exercised in patients with severe anemia or abnormal liver function. 2. Interference with diagnosis: Use of this medication may increase blood bilirubin levels by up to 25%. High doses may cause hemoglobin levels to decrease. 3. Administration should be started as early as possible. Administration within 3 days of the onset of respiratory syncytial viral pneumonia is generally effective. This medication should not be used in patients who have not been laboratory-confirmed to have respiratory syncytial virus infection. 4. Long-term or high-dose use of this medication may have adverse effects on liver function and blood counts.